Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001697817 | SCV000526226 | likely benign | not provided | 2020-10-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000475381 | SCV000561800 | benign | Charcot-Marie-Tooth disease axonal type 2F | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001172563 | SCV001335625 | likely benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Athena Diagnostics Inc | RCV000439558 | SCV001879775 | benign | not specified | 2020-11-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348197 | SCV002650685 | likely benign | Inborn genetic diseases | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001697817 | SCV004563403 | benign | not provided | 2023-11-22 | criteria provided, single submitter | clinical testing |